LabCompass

Xiaoling Xuei

Medicine · Indiana University

OpenAlex ORCID
Chronic Myeloid Leukemia TreatmentsBRCA gene mutations in cancerChronic Lymphocytic Leukemia ResearchGenetic Associations and EpidemiologyPhagocytosis and Immune Regulation

Publications

289

Citations

6,746

Est. group size

~4

Recurring co-author estimate

Active years

35

Publishing since 1992

Research summary
AI-generated

Xiaoling Xuei works in biomedical research focused on cancer biology, particularly breast cancer development and prevention, using genomic and transcriptomic techniques such as single-cell and spatial RNA sequencing. The research also spans immune responses in contexts like melanoma, malaria, and hemophilia, and includes work on standardizing genomic measurement methods. Studies frequently examine how metabolic and lipid-related changes drive gene expression alterations linked to cancer.

Breast cancer biology and preventionSingle-cell and spatial transcriptomicsMetabolic and epigenetic reprogrammingImmune profiling in diseaseGenomic sequencing method evaluation

Publication activity grew steadily over the decade with a notable spike in 2024, suggesting an increasingly active output.

Generated by claude-opus-4-8 from public bibliographic data · Jul 11, 2026

Publication cadence
Publications per year over the last 10 years — averaging 26.8/year recently
2017: 4 publications172018: 4 publications182019: 9 publications192020: 14 publications202021: 17 publications212022: 13 publications222023: 17 publications232024: 84 publications84242025: 4 publications252026: 16 publications26
Recent publications
Publishes in
  • Figshare×24
  • bioRxiv (Cold Spring Harbor Laboratory)×16
  • Cancer Research×4
  • Proceedings of IMPRS×4
  • JCI Insight×3

This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.

Last updated Jul 11, 2026.

Claim or correct this profile